Gene · 7466
Papers1,771
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,771
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Δ8-THC Protects against Amyloid Beta Toxicity Modulating ER Stress In Vitro: A Transcriptomic Analysis. | Int J Mol Sci | 2023 | 37047608 | PubTator, text mining | PubMed |
| WFS1 autosomal dominant variants linked with hearing loss: update on structural analysis and cochlear implant outcome. | BMC Med Genomics | 2023 | 37041640 | PubTator, text mining | PubMed |
| Monogenic diabetes in New Zealand - An audit based revision of the monogenic diabetes genetic testing pathway in New Zealand. | Front Endocrinol (Lausanne) | 2023 | 37033247 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Skin manifestations in rare types of diabetes and other endocrine conditions. | Endocr Connect | 2023 | 37014304 | PubTator, text mining | PubMed |
| GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models. | Diabetologia | 2023 | 36995380 | PubTator, text mining | PubMed |
| Evaluation of the Oral Bacterial Genome and Metabolites in Patients with Wolfram Syndrome. | Int J Mol Sci | 2023 | 36982670 | PubTator, text mining | PubMed |
| Genetic Variants of HNF4A, WFS1, DUSP9, FTO, and ZFAND6 Genes Are Associated with Prediabetes Susceptibility and Inflammatory Markers in the Saudi Arabian Population. | Genes (Basel) | 2023 | 36980809 | PubTator, text mining | PubMed |
| Association of Clinical Aspects and Genetic Variants with the Severity of Cisplatin-Induced Ototoxicity in Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study. | Cancers (Basel) | 2023 | 36980643 | PubTator, text mining | PubMed |
| The Enigmatic Genetic Landscape of Hereditary Hearing Loss: A Multistep Diagnostic Strategy in the Italian Population. | Biomedicines | 2023 | 36979683 | PubTator, text mining | PubMed |
| Community data-driven approach to identify pathogenic founder variants for pan-ethnic carrier screening panels. | Hum Genomics | 2023 | 36978159 | PubTator, text mining | PubMed |
| The melatonin receptor 1B gene links circadian rhythms and type 2 diabetes mellitus: an evolutionary story. | Ann Med | 2023 | 36974476 | PubTator, text mining | PubMed |
| Identification of AFG3L2 dominant optic atrophy following reanalysis of clinical exome sequencing. | Am J Ophthalmol Case Rep | 2023 | 36974169 | PubTator, text mining | PubMed |
| Complex clinical manifestations and new insights in RNA sequencing of children with diabetes and WFS1 variants. | Front Endocrinol (Lausanne) | 2023 | 36967753 | PubTator, text mining | PubMed |
| Epidemiological-molecular profile of variants associated with type 2 diabetes mellitus in indigenous populations from the Brazilian Amazon. | Diabetes Res Clin Pract | 2023 | 36966975 | PubTator, text mining | PubMed |
| Sirtuin 3 mutation- induced mitochondrial dysfunction and optic neuropathy: a case report. | BMC Ophthalmol | 2023 | 36964505 | PubTator, text mining | PubMed |
| Novel WFS1 mutations in patients with low-to-middle frequency hearing loss. | Int J Pediatr Otorhinolaryngol | 2023 | 36958120 | PubTator, text mining | PubMed |
| Generation of induced pluripotent stem cells (IBMSi027-A) from a patient with hearing loss carrying WFS1 c.2051C > T (p.Ala684Val) variant. | Stem Cell Res | 2023 | 36933359 | PubTator, text mining | PubMed |
| The Italian reappraisal of the most frequent genetic defects in hereditary optic neuropathies and the global top 10. | Brain | 2023 | 36913248 | PubTator, text mining | PubMed |
| Molecular Genetics of Abnormal Redox Homeostasis in Type 2 Diabetes Mellitus. | Int J Mol Sci | 2023 | 36902173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7466/papers?page=13